Management of refractory overactive bladder

Maude E. Carmel, Howard B. Goldman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Overactive bladder has significant impact on a patient's quality of life. Conservative and pharmacologic management are effective in most patients. Whereas treatment options were limited many years ago for patients who failed first-line therapy, there are now multiple minimally invasive options for them. Detrusor injection of botulinum toxin, which is not yet officially approved for the treatment of idiopathic overactive bladder, significantly improves patient's symptoms and quality of life, and is well tolerated. Two types of neuromodulation are also available: posterior tibial nerve stimulation and sacral nerve stimulation. Promising new medications are in the pipeline. For those who do not respond to the minimally invasive options, augmentation cystoplasty or urinary diversion remain options.

Original languageEnglish (US)
Pages (from-to)605-613
Number of pages9
JournalExpert Review of Obstetrics and Gynecology
Volume7
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Overactive Urinary Bladder
Quality of Life
Tibial Nerve
Urinary Diversion
Botulinum Toxins
Therapeutics
Injections

Keywords

  • augmentation cystoplasty
  • botulinum toxin
  • posterior tibial nerve stimulation
  • refractory overactive bladder
  • sacral nerve stimulation
  • treatment
  • urinary urge incontinence

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Maternity and Midwifery
  • Pediatrics, Perinatology, and Child Health

Cite this

Management of refractory overactive bladder. / Carmel, Maude E.; Goldman, Howard B.

In: Expert Review of Obstetrics and Gynecology, Vol. 7, No. 6, 11.2012, p. 605-613.

Research output: Contribution to journalArticle

@article{56168eaf997a4987b252a2c12d90e868,
title = "Management of refractory overactive bladder",
abstract = "Overactive bladder has significant impact on a patient's quality of life. Conservative and pharmacologic management are effective in most patients. Whereas treatment options were limited many years ago for patients who failed first-line therapy, there are now multiple minimally invasive options for them. Detrusor injection of botulinum toxin, which is not yet officially approved for the treatment of idiopathic overactive bladder, significantly improves patient's symptoms and quality of life, and is well tolerated. Two types of neuromodulation are also available: posterior tibial nerve stimulation and sacral nerve stimulation. Promising new medications are in the pipeline. For those who do not respond to the minimally invasive options, augmentation cystoplasty or urinary diversion remain options.",
keywords = "augmentation cystoplasty, botulinum toxin, posterior tibial nerve stimulation, refractory overactive bladder, sacral nerve stimulation, treatment, urinary urge incontinence",
author = "Carmel, {Maude E.} and Goldman, {Howard B.}",
year = "2012",
month = "11",
doi = "10.1586/eog.12.60",
language = "English (US)",
volume = "7",
pages = "605--613",
journal = "Expert Review of Obstetrics and Gynecology",
issn = "1747-4108",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Management of refractory overactive bladder

AU - Carmel, Maude E.

AU - Goldman, Howard B.

PY - 2012/11

Y1 - 2012/11

N2 - Overactive bladder has significant impact on a patient's quality of life. Conservative and pharmacologic management are effective in most patients. Whereas treatment options were limited many years ago for patients who failed first-line therapy, there are now multiple minimally invasive options for them. Detrusor injection of botulinum toxin, which is not yet officially approved for the treatment of idiopathic overactive bladder, significantly improves patient's symptoms and quality of life, and is well tolerated. Two types of neuromodulation are also available: posterior tibial nerve stimulation and sacral nerve stimulation. Promising new medications are in the pipeline. For those who do not respond to the minimally invasive options, augmentation cystoplasty or urinary diversion remain options.

AB - Overactive bladder has significant impact on a patient's quality of life. Conservative and pharmacologic management are effective in most patients. Whereas treatment options were limited many years ago for patients who failed first-line therapy, there are now multiple minimally invasive options for them. Detrusor injection of botulinum toxin, which is not yet officially approved for the treatment of idiopathic overactive bladder, significantly improves patient's symptoms and quality of life, and is well tolerated. Two types of neuromodulation are also available: posterior tibial nerve stimulation and sacral nerve stimulation. Promising new medications are in the pipeline. For those who do not respond to the minimally invasive options, augmentation cystoplasty or urinary diversion remain options.

KW - augmentation cystoplasty

KW - botulinum toxin

KW - posterior tibial nerve stimulation

KW - refractory overactive bladder

KW - sacral nerve stimulation

KW - treatment

KW - urinary urge incontinence

UR - http://www.scopus.com/inward/record.url?scp=84870433587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870433587&partnerID=8YFLogxK

U2 - 10.1586/eog.12.60

DO - 10.1586/eog.12.60

M3 - Article

AN - SCOPUS:84870433587

VL - 7

SP - 605

EP - 613

JO - Expert Review of Obstetrics and Gynecology

JF - Expert Review of Obstetrics and Gynecology

SN - 1747-4108

IS - 6

ER -